Entera Bio Ltd.
General ticker "ENTX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $85.9M (TTM average)
Entera Bio Ltd. does not follow the US Stock Market performance with the rate: -12.8%.
Estimated limits based on current volatility of 3.4%: low 1.20$, high 1.29$
Factors to consider:
- Total employees count: 19 (-5.0%) as of 2023
- Top business risk factors: Ability to continue as a going concern, Capital raising, Regulatory and compliance, Labor/talent shortage/retention, Cybersecurity threats
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [1.31$, 3.09$]
- 2026-12-31 to 2027-12-31 estimated range: [1.30$, 3.06$]
Financial Metrics affecting the ENTX estimates:
- Positive: with PPE of -7.1 at the end of fiscal year the price was neutral
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Negative: negative Net income
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: Investing cash flow per share per price, % of -0.13 > -0.60
- Positive: Inventory ratio change, % of 0 <= 0
- Positive: Shareholder equity ratio, % of 81.92 > 64.29
Short-term ENTX quotes
Long-term ENTX plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.18MM | $0.04MM |
| Operating Expenses | $8.94MM | $9.77MM | $11.57MM |
| Operating Income | $-8.94MM | $-9.59MM | $-11.53MM |
| Non-Operating Income | $0.08MM | $0.06MM | $0.09MM |
| R&D Expense | $4.45MM | $4.50MM | $6.00MM |
| Income(Loss) | $-8.86MM | $-9.53MM | $-11.44MM |
| Taxes | $0.03MM | $0.01MM | $0.00MM |
| Net Income(Loss)* | $-8.89MM | $-9.54MM | $-11.44MM |
| Stockholders Equity | $10.39MM | $8.08MM | $13.10MM |
| Assets | $11.77MM | $9.39MM | $15.99MM |
| Operating Cash Flow | $-7.31MM | $-6.82MM | $-7.37MM |
| Capital expenditure | $0.02MM | $0.00MM | $0.11MM |
| Investing Cash Flow | $-0.02MM | $-0.00MM | $-0.11MM |
| Financing Cash Flow | $6.04MM | $4.48MM | $13.71MM |
| Earnings Per Share** | $-0.31 | $-0.25 | $-0.25 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.